Promethazine teoclate

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C17H20N2S.C7H7ClN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S5PUP23U26, chemically known as 8-chloro-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione compd. with n,n,alpha-trimethyl-10h-phenothiazine-10-ethanamine (1:1) but more generally known as promethazine teoclate, which bears US NIH Compound Identifier 63030. European Medicines Agency schedules Promethazine teoclate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10089MIG. The term PROMETHAZINE TEOCLATE is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule promethazine teoclate under HS 29395900 and SITC 54145. As of Q4 2014, PROMETHAZINE TEOCLATE remains US FDA's Preferred Term for this commodity. Promethazine teoclate bears US NLM identifiers UMLS ID C0355411 and NCI Concept Code C66479. SMILES: CC(CN1C2CCCCC2SC3C1CCCC3)N(C)C.CN1C2C(C(=O)N(C1=O)C)[NH]C(N2)CL.